Gilead Sciences

Regional Director - HIV Prevention, Field Activation Specialist - Northeast

Manhattan, New York, United States

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in a related field, with a minimum of 7 years of experience in HIV prevention and/or public health, including demonstrated leadership experience. Strong knowledge of HIV epidemiology, prevention strategies, and healthcare systems is essential, along with excellent communication and interpersonal skills.

Responsibilities

As the Regional Director - HIV Prevention, Field Activation Specialist - Northeast, you will lead by example as a player-coach, partnering with team members to ensure key strategic accounts and institutions are activated. You will actively engage in the field alongside your team, empowering them, providing direct customer engagement, mentoring, and tactical support to drive team success. Additionally, you will recruit, hire, and manage a team of Market Expansion Specialists, ensuring they have the tools, training, and resources to excel, and providing continuous coaching, feedback, and development opportunities.

Skills

HIV prevention
Public health
Leadership
Communication
Interpersonal skills
HIV epidemiology
Healthcare systems
Recruiting
Hiring
Team management
Coaching
Mentoring

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI